Tamura, Ryota
Iwanami, Akio
Ohara, Kentaro
Nishimoto, Masaaki
Pareira, Eriel Sandika
Miwa, Tomoru
Tsuzaki, Naoko
Kuranari, Yuki
Morimoto, Yukina
Toda, Masahiro
Okano, Hideyuki
Nakamura, Masaya
Yoshida, Kazunari
Sasaki, Hikaru http://orcid.org/0000-0001-7380-1931
Funding for this research was provided by:
Japan Society for the Promotion of Science (18J21382, 24791563)
Article History
Received: 16 November 2022
Accepted: 26 February 2023
First Online: 9 March 2023
Declarations
:
: M.N. declared consultancy role with KâPharma Inc. and research funding from RMic and Hisamitsu. H.O. declared a compensated scientific consultancy role for San Bio Co. Ltd, K Pharma Inc and RMic. The other authors declared no potential conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.